SCHEMBL11052886

SCHEMBL11052886

O=C(O)CN(C(=O)CCl)c1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
RAB9A P51151 8/20 0.46
NPC1 O15118 7/20 0.46
HTT P42858 5/20 0.46
PAX8 Q06710 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
GLA P06280 1/20 0.46
JAK2 O60674 3/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RNF4 P78317 1/20 0.42
PTPN7 P35236 1/20 0.41
LMNA P02545 4/20 0.40
TP53 P04637 3/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
CYP1A2 P05177 1/20 0.39
MITF O75030 1/20 0.38
PTGES O14684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5381724 0.82 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1HTTPAX8
SCHEMBL7102909 0.81 PTPN7 (0.42) ALDH1A1SMN1; SMN2KMT2APOLBPTPN7
SCHEMBL8852613 0.77 INSR (0.49) ALDH1A1HTTSMN1; SMN2KMT2ANPSR1
SCHEMBL11503414 0.77 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1HTTPAX8
SCHEMBL9133855 0.75 MTNR1A (0.51) ALDH1A1RAB9ANPC1HTTPAX8
SCHEMBL7191809 0.74 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KMT2APTPN7MEN1
SCHEMBL11739827 0.74 NPC1 (0.49) ALDH1A1RAB9ANPC1HTTPAX8
SCHEMBL28758819 0.74 UTS2R (0.46) ALDH1A1RAB9ANPC1HTTSMN1; SMN2
SCHEMBL11787571 0.74 RNF4 (0.63) ALDH1A1RAB9ANPC1HTTPAX8
SCHEMBL10982478 0.72 BCL2L1 (0.43) ALDH1A1RAB9ANPC1HTTPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4490370-A BACTERICIDES ELI LILLY AND COMPANY (US) 1984-12-25 US disclosed
EP-0122155-A2 Improvements in or relating to naphthylglycyl cephalosporin derivatives ELI LILLY AND COMPANY (US) 1984-10-17 EP disclosed